Skip to Main Content

PHIL in the Treatment of Intracranial dAVF. (PHIL dAVF)

Conditions

Diseases of the Cardiovascular System

What is the purpose of this trial?

Brief Summary:

This study is a prospective, multicenter, single-arm study. Patients with Dural Arteriovenous Fistulas (dAVF) have a few choice for safe treatment. In this study, all patients with qualifying dAVFs will be treated with PHIL® Liquid Embolic material.

  • Trial with
    Microvention-Terumo, Inc.
  • Start Date
    05/02/2019
  • End Date
    05/30/2019
Trial Image

For more information about this study, contact:

Lindsey Fraczkiewicz

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    05/23/2019
  • Study HIC
    #2000023267